Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma (Q74055987)
Jump to navigation
Jump to search
scientific article published on 01 August 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma |
scientific article published on 01 August 2000 |
Statements
Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma (English)
T Hara
H Tsurumi
M Takemura
H Goto
T Yamada
M Sawada
T Takahashi
1 August 2000